Thomas K. Baker

1.1k total citations
28 papers, 818 citations indexed

About

Thomas K. Baker is a scholar working on Molecular Biology, Health, Toxicology and Mutagenesis and Oncology. According to data from OpenAlex, Thomas K. Baker has authored 28 papers receiving a total of 818 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Molecular Biology, 5 papers in Health, Toxicology and Mutagenesis and 5 papers in Oncology. Recurrent topics in Thomas K. Baker's work include Computational Drug Discovery Methods (4 papers), Drug Transport and Resistance Mechanisms (3 papers) and Connexins and lens biology (3 papers). Thomas K. Baker is often cited by papers focused on Computational Drug Discovery Methods (4 papers), Drug Transport and Resistance Mechanisms (3 papers) and Connexins and lens biology (3 papers). Thomas K. Baker collaborates with scholars based in United States, United Kingdom and South Korea. Thomas K. Baker's co-authors include James Stevens, Timothy P. Ryan, James E. Klaunig, George H. Searfoss, Hong Gao, Mark A. Carfagna, A Kwiatkowski, Ernst R. Dow, Qingqin S. Li and Thomas F. Peeper and has published in prestigious journals such as Cancer Research, Journal of Medicinal Chemistry and Lab on a Chip.

In The Last Decade

Thomas K. Baker

27 papers receiving 781 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Thomas K. Baker United States 16 335 130 109 100 95 28 818
Stéphane Dhalluin France 11 341 1.0× 233 1.8× 92 0.8× 195 1.9× 83 0.9× 19 919
Franck A. Atienzar Belgium 11 327 1.0× 243 1.9× 97 0.9× 204 2.0× 75 0.8× 12 913
B. O. Depelchin Belgium 6 266 0.8× 176 1.4× 88 0.8× 144 1.4× 56 0.6× 7 714
Brigitte Gerin Belgium 7 226 0.7× 215 1.7× 132 1.2× 144 1.4× 50 0.5× 11 761
M. R. Slaughter United Kingdom 5 203 0.6× 266 2.0× 77 0.7× 81 0.8× 34 0.4× 9 702
Dolores Diaz United States 15 618 1.8× 270 2.1× 259 2.4× 143 1.4× 53 0.6× 22 1.3k
Naoki Kiyosawa Japan 19 475 1.4× 150 1.2× 63 0.6× 30 0.3× 72 0.8× 46 859
Daniela Ennulat United States 17 296 0.9× 138 1.1× 98 0.9× 27 0.3× 65 0.7× 28 1.0k
Teija Oinonen Finland 13 282 0.8× 233 1.8× 117 1.1× 52 0.5× 53 0.6× 19 699
Annie Borgne‐Sanchez France 14 425 1.3× 267 2.1× 125 1.1× 29 0.3× 31 0.3× 19 1.0k

Countries citing papers authored by Thomas K. Baker

Since Specialization
Citations

This map shows the geographic impact of Thomas K. Baker's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Thomas K. Baker with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Thomas K. Baker more than expected).

Fields of papers citing papers by Thomas K. Baker

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Thomas K. Baker. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Thomas K. Baker. The network helps show where Thomas K. Baker may publish in the future.

Co-authorship network of co-authors of Thomas K. Baker

This figure shows the co-authorship network connecting the top 25 collaborators of Thomas K. Baker. A scholar is included among the top collaborators of Thomas K. Baker based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Thomas K. Baker. Thomas K. Baker is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Shenton, Jacintha, Thomas K. Baker, Rémi Villenave, et al.. (2025). Opportunities and insights from pharmaceutical companies on the current use of new approach methodologies in nonclinical safety assessment. Drug Discovery Today. 30(4). 104328–104328. 4 indexed citations
2.
Baker, Thomas K., et al.. (2025). Culture Is Key: Engaging Culturally and Linguistically Diverse Populations in Breast Cancer Screening in High Income Contexts: A Scoping Review. Cancer Medicine. 14(7). e70817–e70817. 1 indexed citations
3.
Baker, Thomas K., Terry R. Van Vleet, Prathap Kumar S. Mahalingaiah, et al.. (2023). The Current Status and Use of Microphysiological Systems by the Pharmaceutical Industry: The International Consortium for Innovation and Quality Microphysiological Systems Affiliate Survey and Commentary. Drug Metabolism and Disposition. 52(3). 198–209. 10 indexed citations
4.
Pointon, Amy, Jonathan Maher, Thomas K. Baker, et al.. (2021). Cardiovascular microphysiological systems (CVMPS) for safety studies – a pharma perspective. Lab on a Chip. 21(3). 458–472. 13 indexed citations
5.
Brown, Jacquelyn A., Shannon L. Faley, Yajuan Shi, et al.. (2020). Advances in blood–brain barrier modeling in microphysiological systems highlight critical differences in opioid transport due to cortisol exposure. Fluids and Barriers of the CNS. 17(1). 38–38. 32 indexed citations
6.
Willy, Jeffrey A., et al.. (2016). In VitroL6 Irritation Assay Predicts Clinical Injection Site Reactions for Small Molecules. Toxicological Sciences. 151(2). 302–311. 4 indexed citations
7.
Goldstein, Keith M., David E. Seyler, Philippe Durand, Marie‐Hélène Perrard, & Thomas K. Baker. (2016). Use of a rat ex-vivo testis culture method to assess toxicity of select known male reproductive toxicants. Reproductive Toxicology. 60. 92–103. 17 indexed citations
8.
Zamek‐Gliszczynski, Maciej J., et al.. (2013). Minor Compensatory Changes in SAGE Mdr1a (P-gp), Bcrp, and Mrp2 Knockout Rats Do Not Detract from Their Utility in the Study of Transporter-Mediated Pharmacokinetics. Drug Metabolism and Disposition. 41(6). 1174–1178. 17 indexed citations
9.
Bercu, Joel P., Robert A. Jolly, Kelly M. Flagella, et al.. (2010). Toxicogenomics and cancer risk assessment: A framework for key event analysis and dose–response assessment for nongenotoxic carcinogens. Regulatory Toxicology and Pharmacology. 58(3). 369–381. 26 indexed citations
10.
Stevens, James & Thomas K. Baker. (2009). The future of drug safety testing: expanding the view and narrowing the focus. Drug Discovery Today. 14(3-4). 162–167. 208 indexed citations
11.
Guo, Yin, Robert A. Jolly, Thomas K. Baker, et al.. (2007). Underlying Mechanisms of Pharmacology and Toxicity of a Novel PPAR Agonist Revealed Using Rodent and Canine Hepatocytes. Toxicological Sciences. 96(2). 294–309. 31 indexed citations
12.
Baker, Thomas K., et al.. (2006). Changes in motility, gene expression and actin dynamics: Cdk6‐induced cytoskeletal changes associated with differentiation in mouse astrocytes. Journal of Cellular Biochemistry. 99(2). 635–646. 20 indexed citations
13.
Higgins, Marnie A., Brian R. Berridge, Bonnie Mills, et al.. (2003). Gene Expression Analysis of the Acute Phase Response Using a Canine Microarray. Toxicological Sciences. 74(2). 470–484. 48 indexed citations
14.
Baker, Thomas K., et al.. (2003). Involvement of calcium channels in the sexual dimorphism of cadmium-induced hepatotoxicity. Toxicology Letters. 137(3). 185–192. 30 indexed citations
15.
Baker, Thomas K., Mark A. Carfagna, Hong Gao, et al.. (2001). Temporal Gene Expression Analysis of Monolayer Cultured Rat Hepatocytes. Chemical Research in Toxicology. 14(9). 1218–1231. 118 indexed citations
16.
Baker, Thomas K., S Bachowski, D.E. Stevenson, Earl F. Walborg, & James E. Klaunig. (1995). Modulation of gap junctional intercellular communication in rodent, monkey and human hepatocyte by nongenotoxic compounds.. PubMed. 391. 71–80. 15 indexed citations
17.
Baker, Thomas K., A Kwiatkowski, Burra V. Madhukar, & James E. Klaunig. (1995). Inhibition of gap junctional intercellular communication by 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) in rat hepatocytes. Carcinogenesis. 16(10). 2321–2326. 42 indexed citations
18.
Klaunig, James E., Yong Xu, S Bachowski, et al.. (1995). Oxidative stress in nongenotoxic carcinogenesis. Toxicology Letters. 82-83. 683–691. 50 indexed citations
19.
Kwiatkowski, A, Thomas K. Baker, & James E. Klaunig. (1994). Comparison of glucocorticoid-mediated changes in the expression and function of rat hepatocyte gap junctional proteins. Carcinogenesis. 15(8). 1753–1757. 25 indexed citations
20.
Baker, Thomas K., et al.. (1990). Factors Influencing Winter Wheat (Triticum aestivum) Injury from Sulfonylurea Herbicides. Weed Technology. 4(4). 724–730. 26 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Stéphane Dhalluin Breakdown of academic impact, for papers by Franck A. Atienzar Breakdown of academic impact, for papers by B. O. Depelchin Breakdown of academic impact, for papers by Brigitte Gerin Breakdown of academic impact, for papers by M. R. Slaughter Breakdown of academic impact, for papers by Dolores Diaz Breakdown of academic impact, for papers by Naoki Kiyosawa Breakdown of academic impact, for papers by Daniela Ennulat Breakdown of academic impact, for papers by Teija Oinonen Breakdown of academic impact, for papers by Annie Borgne‐Sanchez
Rankless by CCL
2026